{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:33Z","timestamp":1787070873694,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The differential diagnosis of pelvis renalis cancer (PRC) from renal cell cancer (RCC) is difficult. Because of that, in this study, we compared the standardized uptake value (SUV) with positron emission tomography-computed tomography (PET-CT) of the RCC and PRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Twenty-one patients (12 males, 9 females; age range: 33\u201374 years; mean age \u00b1 standard deviation [SD]: 57.14 \u00b1 17.6) with suspected primary renal cell cancer as Group 1 and 8 patients (6 male, 2 female; age range, 61\u201381; mean age \u00b1 SD, 71.5 \u00b1 5.65) with suspected renal pelvis cancer as Group 2 detected by conventional imaging techniques (CT, magnetic resonance [MR] imaging, ultrasound, intravenous urogram, CT urography, MR urography) underwent fluorine-18-fluorodeoxyglucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG) PET\/CT imaging between August 2010 and October 2012.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Mean age is 57.14 (33\u201374) years in Group 1 and 71.5 (61\u201381) years in Group 2, respectively. The mean maximum SUV (SUV\n                      <jats:sub>max<\/jats:sub>\n                      ) value was 4.6 \u00b1 2.1 in RCC group and 16.6 \u00b1 6.9 in PRC group. At the 18-FDG PET\/CT scanning, SUV\n                      <jats:sub>max<\/jats:sub>\n                      value higher in patients with PRC than in the patients with RCC. It was statistically different (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We suggested that PET\/CT can be used for the differential diagnosis of renal pelvis tumor and RCC. However, further studies with larger patient number are needed to confirm our suggestion. To clarify the mechanisms of underlying these differences, molecular advanced molecular studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_217_16","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T04:18:24Z","timestamp":1556597904000},"page":"901-905","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography"],"prefix":"10.4103","volume":"17","author":[{"given":"Murat","family":"Dursun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Otunctemur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Besiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20241021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat Rev Urol"},{"key":"R3-12-20241021","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.eururo.2005.11.035","article-title":"2004 WHO classification of the renal tumors of the adults","volume":"49","author":"Lopez-Beltran","year":"2006","journal-title":"Eur Urol"},{"key":"R4-12-20241021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jama.292.1.97","article-title":"Renal cell carcinoma","volume":"292","author":"Curti","year":"2004","journal-title":"JAMA"},{"key":"R5-12-20241021","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","article-title":"Rising incidence of renal cell cancer in the United States","volume":"281","author":"Chow","year":"1999","journal-title":"JAMA"},{"key":"R6-12-20241021","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00345-010-0555-1","article-title":"Contemporary epidemiology of renal cell carcinoma: Perspectives of primary prevention","volume":"28","author":"Weikert","year":"2010","journal-title":"World J Urol"},{"key":"R7-12-20241021","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/oxfordjournals.aje.a009667","article-title":"Population attributable risk of renal cell cancer in minnesota","volume":"148","author":"Benichou","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R8-12-20241021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0090-4295(92)90450-B","article-title":"Renal pelvic cancer: A review of 611 patients treated in Illinois 1975-1985.Cancer incidence and end results committee","volume":"40","author":"Guinan","year":"1992","journal-title":"Urology"},{"key":"R9-12-20241021","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004728-199005000-00011","article-title":"Large infiltrating renal transitional cell carcinomas: CT and ultrasound features","volume":"14","author":"Bree","year":"1990","journal-title":"J Comput Assist Tomogr"},{"key":"R10-12-20241021","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2214\/AJR.09.2577","article-title":"Imaging and staging of transitional cell carcinoma: Part 2, upper urinary tract","volume":"192","author":"Vikram","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R11-12-20241021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1040-8428(03)00079-9","article-title":"Transitional cell carcinoma of the ureter and renal pelvis","volume":"47","author":"Kirkali","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"R12-12-20241021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5858\/arpa.2012-0136-OA","article-title":"Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma","volume":"137","author":"Vashistha","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R13-12-20241021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00345-012-0945-7","article-title":"Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI","volume":"31","author":"Sufana Iancu","year":"2013","journal-title":"World J Urol"},{"key":"R15-12-20241021","first-page":"623","article-title":"The applications of PET in clinical oncology","volume":"32","author":"Strauss","year":"1991","journal-title":"J Nucl Med"},{"key":"R16-12-20241021","first-page":"801","article-title":"Positron emission tomography: Applications in oncology","volume":"2","author":"Wahl","year":"1994"},{"key":"R17-12-20241021","first-page":"64","article-title":"Correlation between visualization of primary renal cancer by FDG-PET and histopathological findings","volume":"37","author":"Miyauchi","year":"1996","journal-title":"J Nucl Med"},{"key":"R18-12-20241021","first-page":"l4I","article-title":"Evaluation of renal cell carcinoma with whole body FDG-PET [abstract]","volume":"7","author":"Hoh","year":"996:","journal-title":"J Nucl Med l"},{"key":"R19-12-20241021","first-page":"146","article-title":"Positron emission tomography in diagnosis of renal cell carcinoma","volume":"35","author":"Bachor","year":"1996","journal-title":"Urologe A"},{"key":"R20-12-20241021","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/01.ju.0000120241.50061.e4","article-title":"Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma","volume":"171","author":"Kang","year":"2004","journal-title":"J Urol"},{"key":"R21-12-20241021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.eururo.2010.06.032","article-title":"EAU guidelines on renal cell carcinoma: The 2010 update","volume":"58","author":"Ljungberg","year":"2010","journal-title":"Eur Urol"},{"key":"R22-12-20241021","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00261-008-9360-3","article-title":"Detection of upper tract urothelial neoplasms: Sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography","volume":"33","author":"Dillman","year":"2008","journal-title":"Abdom Imaging"},{"key":"R23-12-20241021","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2008.10.024","article-title":"Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria","volume":"181","author":"Wang","year":"2009","journal-title":"J Urol"},{"key":"R24-12-20241021","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.juro.2009.12.031","article-title":"Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy","volume":"183","author":"Takahashi","year":"2010","journal-title":"J Urol"},{"key":"R25-12-20241021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.2472070798","article-title":"Small (<2-cm) upper-tract urothelial carcinoma: Evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography","volume":"247","author":"Takahashi","year":"2008","journal-title":"Radiology"},{"key":"R26-12-20241021","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.crad.2009.11.003","article-title":"MR urography versus retrograde pyelography\/ureteroscopy for the exclusion of upper urinary tract malignancy","volume":"65","author":"Lee","year":"2010","journal-title":"Clin Radiol"},{"key":"R27-12-20241021","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.juro.2010.05.027","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract","volume":"184","author":"Ishikawa","year":"2010","journal-title":"J Urol"},{"key":"R28-12-20241021","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/PAS.0b013e3181aec42a","article-title":"Small endoscopic biopsies of the ureter and renal pelvis: Pathologic pitfalls","volume":"33","author":"Tavora","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R29-12-20241021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAP.0b013e31817145a9","article-title":"Neoplasms of the upper urinary tract: A review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting","volume":"15","author":"Gupta","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"R30-12-20241021","first-page":"575","article-title":"Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival","volume":"21","author":"Younes","year":"2001","journal-title":"Anticancer Res"},{"key":"R31-12-20241021","first-page":"1970","article-title":"Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof","volume":"86","author":"Zhou","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R32-12-20241021","first-page":"2741","article-title":"Reversal of multidrug resistance in renal cell carcinoma by short hairpin RNA targeting MDR1 gene","volume":"125","author":"Hao","year":"2012","journal-title":"Chin Med J (Engl"},{"key":"R33-12-20241021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12885-016-2097-4","article-title":"FDG PET\/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma","volume":"16","author":"Nakaigawa","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_217_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:01Z","timestamp":1787067481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_217_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_217_16","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}